PT969816E - Preparacao de aglomerados de po - Google Patents

Preparacao de aglomerados de po

Info

Publication number
PT969816E
PT969816E PT98911423T PT98911423T PT969816E PT 969816 E PT969816 E PT 969816E PT 98911423 T PT98911423 T PT 98911423T PT 98911423 T PT98911423 T PT 98911423T PT 969816 E PT969816 E PT 969816E
Authority
PT
Portugal
Prior art keywords
boxes
preparation
Prior art date
Application number
PT98911423T
Other languages
English (en)
Inventor
Tsong-Toh Yang
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25232603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT969816(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of PT969816E publication Critical patent/PT969816E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
PT98911423T 1997-03-20 1998-03-16 Preparacao de aglomerados de po PT969816E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82112997A 1997-03-20 1997-03-20

Publications (1)

Publication Number Publication Date
PT969816E true PT969816E (pt) 2005-04-29

Family

ID=25232603

Family Applications (2)

Application Number Title Priority Date Filing Date
PT03020466T PT1393721E (pt) 1997-03-20 1998-03-16 Forma de dosagem de aglomerados de pó
PT98911423T PT969816E (pt) 1997-03-20 1998-03-16 Preparacao de aglomerados de po

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT03020466T PT1393721E (pt) 1997-03-20 1998-03-16 Forma de dosagem de aglomerados de pó

Country Status (26)

Country Link
EP (3) EP1393721B1 (pt)
JP (5) JP3901738B2 (pt)
KR (1) KR100386055B1 (pt)
CN (3) CN100548277C (pt)
AR (1) AR011986A1 (pt)
AT (2) ATE284677T1 (pt)
AU (1) AU741783B2 (pt)
CA (3) CA2481868C (pt)
CL (1) CL2011000050A1 (pt)
CZ (1) CZ295460B6 (pt)
DE (2) DE69840277D1 (pt)
DK (2) DK1393721T3 (pt)
ES (2) ES2316681T3 (pt)
HK (2) HK1061359A1 (pt)
HU (2) HU230274B1 (pt)
ID (1) ID24472A (pt)
IL (1) IL131640A0 (pt)
MY (1) MY120725A (pt)
NO (1) NO328062B1 (pt)
NZ (1) NZ337443A (pt)
PL (3) PL192441B1 (pt)
PT (2) PT1393721E (pt)
SK (1) SK284919B6 (pt)
TW (1) TWI221778B (pt)
WO (1) WO1998041193A1 (pt)
ZA (1) ZA982254B (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723985D0 (en) 1997-11-14 1998-01-14 Zeneca Ltd Pharmaceutical compositions
SE9804000D0 (sv) 1998-11-23 1998-11-23 Astra Ab New composition of matter
SE9804001D0 (sv) 1998-11-23 1998-11-23 Astra Ab New process
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
AU6852900A (en) * 1999-08-20 2001-03-19 Norton Healthcare Ltd Method to produce powders for pulmonary or nasal administration
GB0009612D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic formulations
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
GB0009609D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic compositions
FI20002177A0 (fi) * 2000-10-02 2000-10-02 Orion Yhtymae Oyj Uusi yhdistelmä astman hoitoon
FI20002216A0 (fi) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
FI20002215A0 (fi) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
ITMI20012174A1 (it) * 2001-10-18 2003-04-18 Univ Parma Polvere per somministrazione nasale di farmaci
US7931022B2 (en) 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
EP1452179A1 (en) * 2003-02-27 2004-09-01 CHIESI FARMACEUTICI S.p.A. Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
JP2007501194A (ja) * 2003-08-05 2007-01-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ステロイドとβ模倣薬を含む吸入用薬剤
EP1667687A1 (en) * 2003-09-26 2006-06-14 Schering Corporation Pulmonary disease treatment
CA2543482A1 (en) * 2003-10-28 2005-05-19 Glaxo Group Limited Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
JP2007513139A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 安定性の改善した多粒子組成物
DE602004014805D1 (de) * 2003-12-04 2008-08-14 Pfizer Prod Inc Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten
SE528121C2 (sv) * 2004-03-29 2006-09-05 Mederio Ag Preparering av torrpulver för på förhand uppmätt DPI
IL168603A (en) * 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
DE102006030166A1 (de) * 2006-06-29 2008-01-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tempern
DE102006053375A1 (de) * 2006-11-10 2008-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mischung von Pulvern
TW201024034A (en) 2008-12-30 2010-07-01 Saint Gobain Abrasives Inc Bonded abrasive tool and method of forming
MX2011011123A (es) * 2009-04-24 2011-11-04 Schering Corp Formulaciones de aglomerado utiles en inhaladores de polvo seco.
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
CA2763941A1 (en) 2009-05-29 2010-12-02 Pearl Therapeutics, Inc. Compositions, methods & systems for respiratory delivery of two or more active agents
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations
MY163011A (en) * 2010-04-21 2017-07-31 Chiesi Farm Spa Process for providing particles with reduced electrostatic charges
BR112015022784B1 (pt) 2013-03-15 2023-02-14 Pearl Therapeutics, Inc Método de condicionamento de material cristalino micronizado e sistemas de condicionamento
JP6020489B2 (ja) 2014-02-27 2016-11-02 トヨタ自動車株式会社 昇圧コンバータ及びその制御方法
DK3212212T3 (da) 2014-10-31 2020-12-21 Univ Monash Pulverformulering
EP3400214B1 (en) * 2016-01-08 2024-03-13 Theron Pharmaceuticals, Inc. Dry powder inhaler compositions of 7-azoniabicyclo[2.2.1]heptane derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1520247A (en) 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
US4161516A (en) 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
GB8334494D0 (en) 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
ES2044710T3 (es) * 1990-01-29 1994-01-01 Ciba Geigy Ag Procedimiento y dispositivo de dosificacion de un polvo de granulometria fina.
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
DK0613371T3 (da) * 1991-12-18 2002-05-13 Astrazeneca Ab Ny kombination af formoterol og budesonid
DE69323897T2 (de) * 1992-12-18 1999-11-04 Schering Corp Inhalator für pulverförmige medikamente
EP0721331B1 (en) * 1993-10-01 2001-12-05 AstraZeneca AB Process i
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
EP0806945B1 (en) * 1994-12-22 2003-04-23 AstraZeneca AB Therapeutic preparation for inhalation containing parathyro d hormone, pth

Also Published As

Publication number Publication date
CA2282360C (en) 2004-11-09
ZA982254B (en) 1998-09-17
KR20010005520A (ko) 2001-01-15
AR011986A1 (es) 2000-09-13
CN100518718C (zh) 2009-07-29
CA2481868C (en) 2010-06-15
ES2234102T3 (es) 2005-06-16
JP2010275316A (ja) 2010-12-09
JP2010248260A (ja) 2010-11-04
CN1149076C (zh) 2004-05-12
CN1257423A (zh) 2000-06-21
EP0969816A1 (en) 2000-01-12
PL192441B1 (pl) 2006-10-31
NO994519L (no) 1999-11-19
CN1552310A (zh) 2004-12-08
PL335742A1 (en) 2000-05-08
CA2481868A1 (en) 1998-09-24
JP2006152000A (ja) 2006-06-15
JP2000510478A (ja) 2000-08-15
ES2316681T3 (es) 2009-04-16
SK128099A3 (en) 2000-06-12
JP5523240B2 (ja) 2014-06-18
NZ337443A (en) 2001-04-27
IL131640A0 (en) 2001-01-28
EP1393721A1 (en) 2004-03-03
CZ323399A3 (cs) 2000-02-16
SK284919B6 (sk) 2006-02-02
EP0969816B1 (en) 2004-12-15
ATE284677T1 (de) 2005-01-15
ATE415149T1 (de) 2008-12-15
HUP0002029A3 (en) 2001-02-28
HU226671B1 (en) 2009-06-29
DK1393721T3 (da) 2009-03-30
AU6537898A (en) 1998-10-12
PL204480B1 (pl) 2010-01-29
PT1393721E (pt) 2009-02-02
TWI221778B (en) 2004-10-11
DE69828155T2 (de) 2005-12-22
PL208480B1 (pl) 2011-05-31
CZ295460B6 (cs) 2005-08-17
CA2282360A1 (en) 1998-09-24
DK0969816T3 (da) 2005-03-14
HK1061359A1 (en) 2004-09-17
ID24472A (id) 2000-07-20
DE69840277D1 (de) 2009-01-08
EP2036544B1 (en) 2016-12-28
NO994519D0 (no) 1999-09-17
CA2706634A1 (en) 1998-09-24
HK1021323A1 (en) 2000-06-09
EP2036544A1 (en) 2009-03-18
CN1903179A (zh) 2007-01-31
HU0600845D0 (en) 2007-01-29
EP1393721B1 (en) 2008-11-26
JP2014037446A (ja) 2014-02-27
JP3901738B2 (ja) 2007-04-04
WO1998041193A1 (en) 1998-09-24
NO328062B1 (no) 2009-11-13
DE69828155D1 (de) 2005-01-20
AU741783B2 (en) 2001-12-06
HU230274B1 (hu) 2015-11-30
CN100548277C (zh) 2009-10-14
MY120725A (en) 2005-11-30
CL2011000050A1 (es) 2011-06-24
CA2706634C (en) 2012-10-23
KR100386055B1 (ko) 2003-06-09
HUP0002029A2 (hu) 2000-11-28

Similar Documents

Publication Publication Date Title
PT969816E (pt) Preparacao de aglomerados de po
PT891776E (pt) Composicoes de simeticona/fosfato de calcio anidro
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
ID27092A (id) Pembuatan ftalat anhidrida
PT945132E (pt) Composicao de ibuprofeno
PT877070E (pt) Fosforo fotossensivel
PT973527E (pt) Formulacoes de libertacao prolongada de claritromicina
PT1032396E (pt) Esterilizacao de glucocorticoesteroides
PT1028718E (pt) Formulacao de libertacao prolongada
IS5536A (is) Efnablanda fyrir snyrtivörur
DE59810991D1 (de) Phosphorsäurealkylester
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
PT866179E (pt) Caixa de distribuicao
PT906101E (pt) Formulacoes farmaceuticas de libertacao prolongada contendo mizolastina
DE69828796D1 (de) Hochreine verzweigte alkylsilsesquioxanflüssigkeiten
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
FR2766600B1 (fr) Boitier de telereport
DE29714568U1 (de) Einsatzkasten
NO991148D0 (no) Fremstilling av 1-butyl-4-piperidinyl-metylamin
BR9708592A (pt) Composição anti-hiv compreendo derivados de imida-zol
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
IT1283641B1 (it) Procedimento per la preparazione di cefalosporine
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
ID23663A (id) Persiapan kaprolaktam
NO982749D0 (no) Underpuss-installasjonsboks